Some 350 million people across the world are infected chronically with hepatitis B. Despite global control of the disease being achievable through widespread vaccination, this has not yet been attained.
London School Hygiene & Tropical Medicines / SPL
This content was published in 2010. We do not recommend that you take any clinical decisions based on this information without first ensuring you have checked the latest guidance.
Get unlimited access to all content
You’ve reached your limit of premium articles on The Pharmaceutical Journal for this month.
